Generic Name and Formulations:
Ofloxacin 0.3%; oph. soln; contains benzalkonium chloride.
Indications for OCUFLOX:
Susceptible infections of the conjuctiva and corneal ulcer.
Adults and Children:
<1yr: not recommended. ≥1yr: Conjunctivitis: 1–2 drops every 2–4 hrs for 2 days, then 4 times daily for 5 more days. Corneal ulcer: 1–2 drops every 30 minutes while awake and at 4 hrs & 6 hrs after retiring for sleep for 2 days, then 1–2 drops every 1 hr while awake for days 3 through 7–9, then 1–2 drops 4 times daily through treatment completion.
Discontinue if superinfection or hypersensitivity occurs. Pregnancy (Cat.C). Nursing mothers: not recommended.
Possible potentiation of theophylline, caffeine, oral anticoagulants, cyclosporine if systemic absorption occurs.
Superinfection, photophobia, lacrimation, transient local reactions including burning, stinging, redness, itching, dry eye; anaphylaxis, Stevens-Johnson syndrome (rare).
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV
- Maintenance rTMS for Treatment-Resistant Depression
- New Study Compares Opioid Dependence Relapse Treatments
- Increase Use of Nursing Home for Patients With Cognitive Impairment Category
- Venlafaxine XR Safe, Effective in Treating Generalized Anxiety Disorder